Intercept Pharma (ICPT) Chief Medical Officer Jason Campagna Resigns to Pursue Other Opportunities

Intercept Pharma (NASDAQ: ICPT) disclosed:

On February 18, 2021, Jason Campagna, M.D., Ph.D., notified Intercept Pharmaceuticals, Inc. (the “Company”) of his decision to resign from his position as the Company’s Chief Medical Officer, effective March 5, 2021, in order to pursue other opportunities. Dr. Campagna’s resignation was not the result of any disagreement regarding any matter related to the Company’s operations, policies, or practices.

Gail Cawkwell will serve as acting Chief Medical Officer pending appointment of a permanent replacement.

You May Also Be Interested In

• Willdan Group (WLDN) Announces CFO Transition
• Duke Energy (DUK) responds to North Carolina Utilities Commission's decision on Duke Energy Progress' 2019 rate request
• Tencent Music (TME) Appoints Zhu Liang as New CEO; Announces Cussion Kar Shun Pang as New Executive Board Chair